A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile

International Journal of Infectious Diseases

Volumn 12, Issue 6, 2008, Pages 645-652

  Balcells, María Elvira ^a   Pérez, Carlos M ^a   Chanqueo, Leonardo ^b   Lasso, Martín ^c   Villanueva, Marcela ^a   Espinoza, Mónica ^a   Villarroel, Luis ^a   García, Patricia ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b HOSPITAL SAN JUAN DE DIOS   (Chile)

^c NONE

Author keywords

Diagnosis; HIV; Interferon gamma; Latent tuberculosis; Tuberculin skin test; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; GAMMA INTERFERON; PROTEIN DERIVATIVE;

ADULT; AGED; ARTICLE; BIOASSAY; BLOOD EXAMINATION; CD4 LYMPHOCYTE COUNT; CHEMOPROPHYLAXIS; CHILE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; SINGLE BLIND PROCEDURE; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; CHILE; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 54349124361     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2008.03.005     Document Type: Article

References (31)

1. World Health Organization. Tuberculosis. Data and country profiles. Available at: www.who.int/tb/publications/global_report/2008/chapter_1/en/index3.html (accessed April 2008).
2. Woldehanna S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2004;(1):CD000171.
3. Fisk T.L., Hon H.M., Lennox J.L., Reyn C.F., and Horsburgh Jr. C.R. Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapy. AIDS 17 (2003) 1102-1104
4. Wang L., Turner M.O., Elwood R.K., Schulzer M., and Fitzgerald J.M. A meta-analysis of the effect of bacille Calmette-Guérin vaccination on tuberculin skin test measurements. Thorax 57 (2002) 804-809
5. Weir R.E., Black G.F., Nazareth B., Floyd S., Stenson S., Stanley C., et al. The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guerin vaccination in southern England and northern Malawi. Clin Exp Immunol 146 (2006) 390-399
6. Farhat M., Greenaway C., Pai M., and Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?. Int J Tuberc Lung Dis 10 (2006) 1192-1204
7. Lee L.M., Lobato M.N., Buskin S.E., Morse A., and Costa S. Low adherence to guidelines for preventing TB among persons with newly diagnosed HIV infection, United States. Int J Tuberc Dis 10 (2006) 209-214
8. Zúñiga G., Valenzuela P., Farga V., Yánez A., and Rojas M. Programa Nacional de Control de Tuberculosis. Manual de organización y normas técnicas 2005. 3rd ed. (2005), Editora e Imprenta Naval, Santiago
9. Villarroel L., Rabagliati R., Balcells M.E., Karzulovic L., and Pérez C. Prevalence of tuberculosis and its impact on mortality among HIV infected patients in Chile. Rev Med Chile 136 (2008) 575-582
10. Mazurek G.H., Jereb J., Lobue P., Iademarco M.F., Metchock B., and Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 54 RR-15 (2005) 49-55
11. Andersen P., Munk M.E., Pollock J.M., and Doherty T.M. Specific immune-based diagnosis of tuberculosis. Lancet 356 (2000) 1099-1104
12. Behr M.A., Wilson M.A., Gill W.P., Salamon H., Schoolnik G.K., Rane S., et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284 (1999) 1520-1523
13. Arend S.M., van Meijgaarden K.E., de Boer K., de Palou E.C., Van Soolingen D., Ottenhoff T.H., et al. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii. J Infect Dis 186 (2002) 1797-1807
14. Mori T., Sakatani M., Yamagishi F., Takashima T., Kawabe Y., Nagao K., et al. Specific detection of tuberculosis infection. An interferon-γ based assay using new antigens. Am J Respir Crit Care Med 170 (2004) 59-64
15. Van Pinxteren L.A., Ravn P., Agger E.M., Pollock J., and Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CPF10. Clin Diagn Lab Immunol 7 (2000) 155-160
16. Dewan P.K., Grinsdale J., and Kawamura L.M. Low sensitivity of a whole-blood interferon-γ release assay for detection of active tuberculosis. Clin Infect Dis 44 (2007) 69-73
17. Converse P.J., Jones S.L., Astemborski J., Vlahov D., and Graham N.M. Comparison of a tuberculin interferon-γ assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J Infect Dis 176 (1997) 144-150
18. Brock I., Ruhwald M., Lundgren B., Westh H., Mathiesen L.R., and Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-γ test. Respir Res 7 (2006) 56
19. Rangaka M.X., Wilkinson K.A., Seldon R., Van Cutsem G., Meintjes G.A., Morroni C., et al. Effect of HIV-1 infection on T- cell based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 175 (2007) 514-520
20. Landis R.J., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
21. Markowit N., Hansen N.I., Wilcosky T.C., Hopewell P.C., Glassroth J., Kvale P.A., et al. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group. Ann Intern Med 119 (1993) 185-193
22. Graham N.M., Nelson K.E., Solomon L., Bonds M., Rizzo R.T., Scavotto J., et al. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA 267 (1992) 369-373
23. Sutherland R., Yang H., Scriba T.J., Ondondo B., Robinson N., Conlon C., et al. Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART. AIDS 20 (2006) 821-829
24. Matee M., Lahey T., Vuola J.M., Mtei L., Cole B.F., Bakari M., et al. Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial. J Infect Dis 195 (2007) 118-123
25. Ferrara G., Losi M., D'Amico R., Roversi P., Piro R., Meacci M., et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367 (2006) 1328-1334
26. Ferrara G., Losi M., Meacci M., Meccugni B., Piro R., Roversi P., et al. Routine hospital use of a new commercial whole blood interferon-γ assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 172 (2005) 631-635
27. Mahomed H., Hughes E.J., Hawkridge T., Minnies D., Simon E., Little F., et al. Comparison of Mantoux skin test with three generations of a whole blood IFN-γ assay for tuberculosis infection. Int J Tuberc Lung Dis 10 (2006) 310-316
28. Luetkemeyer A.F., Charlebois E.D., Flores L.L., Bangsberg D.R., Deeks S.G., Martin J.N., et al. Comparison of an interferon-γ release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 175 (2007) 737-742
29. Elzi L., Schlegel M., Weber R., Hirschel B., Cavassini M., Schmid P., et al. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis 44 (2007) 94-102
30. Wilkinson K.A., Kon O.M., Newton S.M., Meintjes G., Davidson R.N., Pasvol G., et al. Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J Infect Dis 193 (2006) 354-359
31. Chee C.B., KhinMar K.W., Gan S.H., Barkham T.M., Pushparani M., and Wang Y.T. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens. Am J Respir Crit Care Med 175 (2007) 282-287